Biotechnology Ultrasector's market value is the price at which a share of Biotechnology Ultrasector trades on a public exchange. It measures the collective expectations of Biotechnology Ultrasector Profund investors about its performance. Biotechnology Ultrasector is trading at 70.97 as of the 31st of January 2026; that is 0.95 percent up since the beginning of the trading day. The fund's open price was 70.3. With this module, you can estimate the performance of a buy and hold strategy of Biotechnology Ultrasector Profund and determine expected loss or profit from investing in Biotechnology Ultrasector over a given investment horizon. Check out Biotechnology Ultrasector Correlation, Biotechnology Ultrasector Volatility and Biotechnology Ultrasector Performance module to complement your research on Biotechnology Ultrasector.
It's important to distinguish between Biotechnology Ultrasector's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biotechnology Ultrasector should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Biotechnology Ultrasector's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biotechnology Ultrasector 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biotechnology Ultrasector's mutual fund what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biotechnology Ultrasector.
0.00
11/02/2025
No Change 0.00
0.0
In 2 months and 31 days
01/31/2026
0.00
If you would invest 0.00 in Biotechnology Ultrasector on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding Biotechnology Ultrasector Profund or generate 0.0% return on investment in Biotechnology Ultrasector over 90 days. Biotechnology Ultrasector is related to or competes with Internet Ultrasector, Columbia Adaptive, Biotechnology Ultrasector, Royce Small-cap, Ashmore Emerging, Ashmore Emerging, and Neuberger Berman. The index is designed to measure the performance of biotechnology companies included in the SP Total Market Index More
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biotechnology Ultrasector's mutual fund current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biotechnology Ultrasector Profund upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotechnology Ultrasector's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biotechnology Ultrasector's standard deviation. In reality, there are many statistical measures that can use Biotechnology Ultrasector historical prices to predict the future Biotechnology Ultrasector's volatility.
Biotechnology Ultrasector appears to be very steady, given 3 months investment horizon. Biotechnology Ultrasector secures Sharpe Ratio (or Efficiency) of 0.16, which signifies that the fund had a 0.16 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Biotechnology Ultrasector Profund, which you can use to evaluate the volatility of the entity. Please makes use of Biotechnology Ultrasector's Risk Adjusted Performance of 0.1198, downside deviation of 2.32, and Mean Deviation of 1.85 to double-check if our risk estimates are consistent with your expectations. The fund shows a Beta (market volatility) of 1.0, which signifies possible diversification benefits within a given portfolio. Biotechnology Ultrasector returns are very sensitive to returns on the market. As the market goes up or down, Biotechnology Ultrasector is expected to follow.
Auto-correlation
0.57
Modest predictability
Biotechnology Ultrasector Profund has modest predictability. Overlapping area represents the amount of predictability between Biotechnology Ultrasector time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biotechnology Ultrasector price movement. The serial correlation of 0.57 indicates that roughly 57.0% of current Biotechnology Ultrasector price fluctuation can be explain by its past prices.
Correlation Coefficient
0.57
Spearman Rank Test
0.57
Residual Average
0.0
Price Variance
4.73
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Ultrasector financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Ultrasector security.